Walder Wyss Attorneys at Law

pdf 308 KB

Life Science Law Newsletter 4

Therapiewahlfreiheit vs. Wirtschaftlichkeitsgebot im Bereich der Spezialitätenliste

by Andreas Wildi, Daniel Staffelbach and Stephanie Eggimann
November 2020

pdf 300 KB

Life Science Law Newsletter 4

Liberté de choix de la thérapie vs principe du caractère économique dans le domaine de la liste des spécialités

by Andreas Wildi, Daniel Staffelbach and Stephanie Eggimann
November 2020

pdf 509 KB

Life Science Law Newsletter 3

Update: Postponement of EU Medical Device Regulation implementation due to COVID-19

by Andreas Wildi and Monja Sieber
May 2020

pdf 267 KB

The Life Sciences Law Review Chapter 28 - Switzerland

by Andreas Wildi and Celine Weber
in: The Life Sciences Law Review - 8th Edition, pp. 412 - 525, May 2020

pdf 537 KB

Life Science Law Newsletter 3

Postponement of EU Medical Device Regulation implementation due to COVID-19

by Andreas Wildi and Monja Sieber
April 2020

Art. 40, 52, 52a KVG

by Andreas Wildi
Editor[s]: Blechta, Colatrella, Rüedi, Staffelbach
"Basler Kommentar - Krankenversicherungsgesetz, Krankenversicherungsaufsichtsgesetz"
2020

Die Abgrenzung von Lebensmitteln und Heilmitteln
[The distinction between food and therapeutic products]

by Andreas Wildi and Sophie Regenfuss
Editor[s]: Daniel Donauer/Hugh Reeves/Celine Weber
"Lebensmittel- und Gebrauchsgegenständerecht"
Zürich, 2020

pdf 120 KB

Life Science Law Monthly Update 5

Life Science Law Update

by Andreas Wildi, Celine Weber and Felix Tuchschmid
December 2019

pdf 123 KB

Life Science Law Monthly Update 4

Life Science Law Update

by Andreas Wildi, Celine Weber and Felix Tuchschmid
November 2019

pdf 106 KB

Life Science Law Monthly Update 3

Life Science Law Update

by Andreas Wildi, Celine Weber and Felix Tuchschmid
October 2019

pdf 105 KB

Life Science Law Monthly Update 2

Life Science Law Update

by Andreas Wildi, Celine Weber and Felix Tuchschmid
September 2019

pdf 122 KB

Life Science Law Monthly Update 1

Life Science Law Update

by Andreas Wildi, Celine Weber and Felix Tuchschmid
July 2019

pdf 310 KB

The Life Sciences Law Review Chapter 29 - Switzerland

by Andreas Wildi and Celine Weber
in: The Life Sciences Law Review - 7th Edition, pp. 405-416, 1 April 2019

pdf 373 KB

Pharmaceutical Advertising - Switzerland

by Andreas Wildi and Celine Weber
in: Chambers Global Practice Guide, 25 March 2019

pdf 180 KB

Arzneimittel sind kein knappes Gut
[Medicines are not a rare commodity]

by Andreas Wildi
in: Neue Zürcher Zeitung, 23 June 2018

Chapter 16: Switzerland

by Andreas Wildi [co-author], Markus R. Frick [co-author], Marija Petrovic [co-author], Benno Fischer-Siddiqui [co-author] and Monika Kawa [co-author]
in: van Wyk/Kleyn (Ed.) (Editor[s]), "International Pharmaceutical Law and Practice"
2018

Publications

Andreas Wildi

Therapiewahlfreiheit vs. Wirtschaftlichkeitsgebot im Bereich der Spezialitätenliste

Liberté de choix de la thérapie vs principe du caractère économique dans le domaine de la liste des spécialités

Update: Postponement of EU Medical Device Regulation implementation due to COVID-19

The Life Sciences Law Review Chapter 28 - Switzerland

Postponement of EU Medical Device Regulation implementation due to COVID-19

Art. 40, 52, 52a KVG

Die Abgrenzung von Lebensmitteln und Heilmitteln [The distinction between food and therapeutic products]

Life Science Law Update

Life Science Law Update

Life Science Law Update

Life Science Law Update

Life Science Law Update

The Life Sciences Law Review Chapter 29 - Switzerland

Pharmaceutical Advertising - Switzerland

Arzneimittel sind kein knappes Gut [Medicines are not a rare commodity]

Chapter 16: Switzerland

Die Abgrenzung von Lebensmitteln und Heilmitteln
[The distinction between food and therapeutic products]

Arzneimittel sind kein knappes Gut
[Medicines are not a rare commodity]